News from depomed, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jul 25, 2014, 16:01 ET

Depomed To Report Second Quarter Fiscal Year 2014 Financial Results On Wednesday, August 6, 2014

 Depomed, Inc. (NASDAQ: DEPO) today announced that it will release second quarter fiscal year 2014 financial results after the market closes...

Jul 17, 2014, 15:38 ET

Depomed Announces District Court Order in ANDA Litigation

 Depomed, Inc. (Nasdaq: DEPO) today announced that on July 17, 2014, Judge Joel A. Pisano of the United States District Court for the...

Jul 16, 2014, 08:00 ET

Depomed Announces Appointment of Srinivas G. Rao, MD, PhD, as Chief Medical Officer

 Depomed, Inc. (Nasdaq: DEPO) today announced the appointment of Srinivas G. Rao, MD, PhD, as Chief Medical Officer and Senior Vice...

Jun 18, 2014, 08:00 ET

Depomed To Present AT JMP Securities 2014 Healthcare Conference

 Depomed, Inc. (NASDAQ:DEPO) today announced that it will be presenting at the JMP Securities 2014 Healthcare Conference in New York City. The...

Jun 10, 2014, 08:00 ET

Depomed to Present at Wells Fargo 2014 Healthcare Conference

Depomed, Inc. (NASDAQ:DEPO) today announced that it will be presenting at the Wells Fargo 2014 Healthcare Conference in Boston. The presentation...

May 28, 2014, 08:10 ET

Mallinckrodt New Drug Application For MNK-155 Accepted For Review By FDA

 Depomed, Inc. (NASDAQ:DEPO)  announced today that the U. S. Food and Drug Administration (FDA) has accepted for filing a New Drug...

May 27, 2014, 16:05 ET

Depomed To Present At Jefferies 2014 Global Healthcare Conference

Depomed, Inc. (NASDAQ: DEPO) today announced that it will be presenting at the Jefferies 2014 Global Healthcare Conference in New York City. The...

May 09, 2014, 16:01 ET

Depomed To Present At Bank of America Merrill Lynch Healthcare Conference And UBS Global Healthcare Conference

Depomed, Inc. (NASDAQ:DEPO) today announced that it will be presenting at two upcoming investor conferences: Bank of America Merrill Lynch...

May 08, 2014, 16:01 ET

Depomed Reports First Quarter 2014 Financial Results

 Depomed, Inc. (Nasdaq: DEPO), today reported financial results for the first quarter ended March 31, 2014. First Quarter 2014 Business...

Apr 30, 2014, 16:05 ET

Depomed To Report First Quarter Fiscal Year 2014 Financial Results On Thursday, May 8, 2014

Depomed, Inc. (NASDAQ:DEPO) today announced that it will release first quarter fiscal year 2014 financial results after the market closes...

Apr 14, 2014, 08:00 ET

Depomed Announces Settlements with Two Gralise® ANDA Filers

Depomed, Inc. (Nasdaq: DEPO) today announced it has entered into settlement agreements with two of the three defendants involved in Depomed's...

Mar 12, 2014, 16:01 ET

Depomed Reports Fourth Quarter and Full Year 2013 Financial Results

Depomed, Inc. (Nasdaq: DEPO), today reported financial results for the quarter and twelve months ended December 31, 2013. 2013 Business and...

Mar 12, 2014, 08:45 ET

Depomed Earns $10 Million Milestone for FDA Approval of Mallinckrodt's XARTEMIS™ XR (oxycodone hydrochloride and acetaminophen) Extended-Release Tablets (CII)

Depomed, Inc. (Nasdaq: DEPO) today announced that the U.S. Food and Drug Administration (FDA) approved Mallinckrodt plc's New Drug Application...

Mar 10, 2014, 17:30 ET

Depomed To Report Fourth Quarter Fiscal Year 2013 Financial Results On Wednesday, March 12, 2014

Depomed, Inc. (NASDAQ: DEPO) today announced that it will release fourth quarter fiscal year 2013 financial results after the market closes...

Mar 05, 2014, 16:15 ET

Depomed To Present At The 26th Annual ROTH Conference On Monday, March 10, 2014

 Depomed, Inc. (NASDAQ: DEPO) today announced that it will be presenting at the 26th Annual ROTH Conference on Monday, March 10, 2014, at the...

Feb 25, 2014, 16:05 ET

Depomed Reports Preliminary Q4 2013 and Full Year Financial Information

Depomed, Inc. (Nasdaq: DEPO) today reported preliminary financial results (unaudited) for the fourth quarter ended December 31, 2013 in...

Feb 20, 2014, 14:00 ET

Depomed To Present At Upcoming Healthcare Conferences

Depomed, Inc. (NASDAQ:DEPO) today announced that it will be presenting at the 2014 RBC Capital Markets' Healthcare Conference at The New York...

Jan 29, 2014, 08:00 ET

Depomed Announces Favorable Markman Ruling in GRALISE® Patent Litigation

 Depomed, Inc. (NASDAQ: DEPO) announced today a favorable "Markman" claim construction ruling by Judge Joel A. Pisano of the United States...

Dec 17, 2013, 16:05 ET

Depomed Acquires CAMBIA® (Diclofenac Potassium for Oral Solution) Migraine Medicine from Nautilus Neurosciences for $48.7 Million

 Depomed, Inc. (NASDAQ: DEPO) today announced that it has acquired the United States rights to CAMBIA® (diclofenac potassium for oral...

Dec 02, 2013, 08:00 ET

Depomed To Present At Piper Jaffray 2013 Healthcare Conference

Depomed, Inc. (NASDAQ:DEPO) today announced that it will be presenting at the Piper Jaffray 25th Annual Healthcare Conference at The New York...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge